Bold integration of biomedical and behavioral science will result in successful HIV Prevention. Our Prevention Core leadership includes Co-Directors Michelle Lally, MD, MSc and Larry Brown, MD. With a shared passion for HIV prevention and a shared vision of novel """"""""biobehavioral"""""""" approaches to HIV prevention. Dr. Lally investigates HIV Vaccines and PrEP, and Dr. Brown's extensive experience and expertise is in behavioral science. Additional Core Faculty, all superb and each committed to the combination of biomedical and behavioral science, include Michael Carey, PhD, Director of Centers for Behavioral and Preventive Medicine at Lifespan, Don Operario, PhD, Director of Graduate Program in Behavioral and Social Sciences Intervention, Brown Program in Public Health, Kate Morrow, PhD (microbicide acceptability). Curt Beckwith, MD (HIV testing and treatment among prisoners and other marginalized populations), Steve Hong, MD (international HIV primary and secondary prevention), and Kenneth Mayer, MD (broad HIV prevention experience and expertise). A red ribbon imprinted with """"""""B &B"""""""" is our Core's logo, which has been effective at promoting the Biomedical &Behavioral branding of our Prevention Core.
Our Aims are to provide HIV prevention researchers (students /junior investigators / experienced investigators) with consultation and mentorship, education and training, and support services that are consistently inclusive of both biomedical and behavioral science.
Aims will be achieved through effective advertising of our services, individual consultations and ongoing mentorship of junior investigators, education and training (on a weekly, monthly, quarterly, or annual basis), and community collaboration. Expected outcomes are sustained and increased funding for research related to HIV prevention among our investigators, continued growth in the number of Core users, increased frequency of use of Core services, and a steady increase in the number of individual prevention projects that cleariy incorporate both biomedical and behavioral science. Outcomes will be tracked and measured, and adjustments will be made to our approaches as necessary to assure that outcomes are achieved.

Public Health Relevance

HIV is a preventable infection, and AIDS is a preventable disease;yet prevention success can be achieved only when effective biological products are combined with requisite behavioral methodologies. The Prevention Core proposes to strategically support HIV prevention efforts with a combination of biomedical and behavioral science through the provision of expert

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-17
Application #
8685868
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
17
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
City
Providence
State
RI
Country
United States
Zip Code
02906
Murphy, Matthew; Berns, Abby L; Bandyopadhyay, Utpala et al. (2018) Varicella in the prison setting: A report of three outbreaks in Rhode Island and a review of the literature. Vaccine 36:5651-5656
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens. J Clin Microbiol 56:
Peloquin, Charles A; Phillips, Patrick P J; Mitnick, Carole D et al. (2018) Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrob Agents Chemother 62:
Linas, Benjamin P; Nolen, Shayla (2018) A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am 32:447-459
Carroll, Jennifer J; Rich, Josiah D; Green, Traci C (2018) The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible. J Addict Med 12:459-465
Coleman, Sharon M; Gnatienko, Natalia; Lloyd-Travaglini, Christine A et al. (2018) False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. HIV Clin Trials 19:15-22
Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X et al. (2018) Zika Virus Exposure in an HIV-Infected Cohort in Ghana. J Acquir Immune Defic Syndr 78:e35-e38
N'Guessan, Kombo F; Boyce, Ceejay; Kwara, Awewura et al. (2018) Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Virus Genes 54:361-367
Freiman, J Morgan; Jacobson, Karen R; Muyindike, Winnie R et al. (2018) Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr 77:405-412
Chan, Philip A; Crowley, Christina; Rose, Jennifer S et al. (2018) A Network Analysis of Sexually Transmitted Diseases and Online Hookup Sites Among Men Who Have Sex With Men. Sex Transm Dis 45:462-468

Showing the most recent 10 out of 806 publications